VRDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Viridian Therapeutics, Inc.\DE
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$20.80+1.77 (+9.30%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Mar 26, 2021(first seen in filings) | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Nov 13, 2020 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Mar 24, 2017(first seen in filings) | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Nov 7, 2016 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Mar 27, 2015(first seen in filings) | 1-for-13 reverse | Earlier per-share figures multiplied by 13 |